English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  51902125    Online Users :  973
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"liu c j"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 811-835 of 1268  (51 Page(s) Totally)
<< < 28 29 30 31 32 33 34 35 36 37 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-03-09T01:47:35Z Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial Liu C.-H.; Liu C.-J.; Huang C.-F.; Lin J.-W.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Lee C.-Y.; Chen S.-I.; Yang S.-S.; TUNG-HUNG SU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:35Z Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; TUNG-HUNG SU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L.
臺大學術典藏 2021-03-09T01:47:35Z Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers Tseng T.-C.; Liu C.-J.; Yang H.-C.; Chen C.-L.; Yang W.-T.; Tsai C.-S.; Kuo S.F.-T.; Verbree F.C.; TUNG-HUNG SU; Wang C.-C.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:34Z Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study Liu C.-H.; Sheng W.-H.; Sun H.-Y.; Hsieh S.-M.; Lo Y.-C.; Liu C.-J.; TUNG-HUNG SU; Yang H.-C.; Liu W.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:34Z Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study TUNG-HUNG SU; Liu C.-J.; Tseng T.-C.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Wu S.-J.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:33Z Hepatitis B surface antigen loss and hepatocellular carcinoma development in patients with dual hepatitis B and C infection Yang W.-T.; Wu L.-W.; Tseng T.-C.; Chen C.-L.; Yang H.-C.; TUNG-HUNG SU; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Liu C.-J.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:32Z Hyperglycemia combined Helicobacter pylori infection increases risk of synchronous colorectal adenoma and carotid artery plaque Hu K.-C.; Wu M.-S.; Chu C.-H.; Wang H.-Y.; Lin S.-C.; Po H.L.; Bair M.-J.; Liu C.-C.; TUNG-HUNG SU; Chen C.-L.; Liu C.-J.; Shih S.-C.
臺大學術典藏 2021-03-09T01:47:32Z Associated factors and clinical implications of serum aminotransferase elevation in scrub typhus TUNG-HUNG SU; Liu C.-J.; Shu P.-Y.; Fu Y.-H.; Chang C.-H.; Jao P.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:30Z Impact of occult hepatitis B on the clinical outcomes of patients with chronic hepatitis C virus infection: A 10-year follow-up Chen H.-Y.; TUNG-HUNG SU; Tseng T.-C.; Yang W.-T.; Chen T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.; Liu C.-J.
臺大學術典藏 2021-03-09T01:47:29Z Combination therapy for chronic hepatitis B: Current updates and perspectives TUNG-HUNG SU; Liu C.-J.
臺大學術典藏 2021-03-09T01:43:25Z Hepatitis B virus reactivation in patients receiving interferon-free direct-acting antiviral agents for chronic hepatitis C virus infection Liu C.-H.; Liu C.-J.; TUNG-HUNG SU; Fang Y.-J.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:43:25Z Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular Carcinoma Tseng T.-C.; Liu C.-J.; TUNG-HUNG SU; Yang W.-T.; Chen C.-L.; Yang H.-C.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:43:24Z Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus Infection Liu C.-H.; Chen Y.-S.; Wang S.-S.; Liu C.-J.; TUNG-HUNG SU; Yang H.-C.; Hong C.-M.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:43:24Z A noninvasive diagnosis of hepatic fibrosis by BioFibroScore® in chronic hepatitis C patients Liu C.-H.; Liu C.-J.; Hong C.-M.; TUNG-HUNG SU; Yang H.-C.; Chen K.-M.; Huang Y.-P.; Yeh Y.-M.; Tien H.-L.; Liu Y.-C.; Kao J.-H.; Chen D.-S.; Chen P.-J.
臺大學術典藏 2021-03-09T01:43:24Z Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis TUNG-HUNG SU; Shiau C.-W.; Jao P.; Yang N.-J.; Tai W.-T.; Liu C.-J.; Tseng T.-C.; Yang H.-C.; Liu C.-H.; Huang K.-W.; Hu T.-C.; Huang Y.-J.; Wu Y.-M.; Chen L.-J.; Chen P.-J.; Chen D.-S.; Chen K.-F.; Kao J.-H.
臺大學術典藏 2021-03-09T01:43:23Z Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan Liu C.-H.; Liu C.-J.; TUNG-HUNG SU; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:43:22Z Age and gender may be the key points in hyperglycemic patients with Helicobacter pylori infection combined colorectal adenoma Kuo Y.-C.; Shih S.-C.; Yu L.-Y.; Wu M.-S.; TUNG-HUNG SU; Liu C.-J.; Hu K.-C.
臺大學術典藏 2021-03-09T01:43:22Z Distinct Relapse Rates and Risk Predictors after Discontinuing Tenofovir and Entecavir Therapy TUNG-HUNG SU; Yang H.-C.; Tseng T.-C.; Liou J.-M.; Liu C.-H.; Chen C.-L.; Chen P.-J.; Chen D.-S.; Liu C.-J.; Kao J.-H.
臺大學術典藏 2021-03-09T01:43:21Z Acoustic radiation force impulse US imaging: Liver stiffness in patients with chronic hepatitis B with and without antiviral therapy TUNG-HUNG SU; Liao C.-H.; Liu C.-H.; Huang K.-W.; Tseng T.-C.; Yang H.-C.; Liu C.-J.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:43:21Z Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection Tseng T.-C.; Liu C.-J.; TUNG-HUNG SU; Yang W.-T.; Chen C.-L.; Yang H.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:43:21Z Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection Liu C.-H.; Sun H.-Y.; Liu C.-J.; Sheng W.-H.; Hsieh S.-M.; Lo Y.-C.; Liu W.-C.; TUNG-HUNG SU; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏 2021-03-09T01:43:20Z Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan Liu C.-H.; Liu C.-J.; TUNG-HUNG SU; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:43:20Z Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study Liu C.-H.; Huang Y.-J.; Yang S.-S.; Chang C.-H.; Yang S.-S.; Sun H.-Y.; Liu C.-J.; Liu W.-C.; TUNG-HUNG SU; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏 2021-03-09T01:43:20Z Significance of definitions of relapse after discontinuation of oral antivirals in HBeAg-negative chronic hepatitis B Papatheodoridis G.V.; Manolakopoulos S.; TUNG-HUNG SU; Siakavellas S.; Liu C.-J.; Kourikou A.; Yang H.-C.; Kao J.-H.
臺大學術典藏 2021-03-09T01:43:19Z Profile and value of FIB-4 in patients with dual chronic hepatitis C and B Liu C.-J.; Tseng T.-C.; Yang W.-T.; TUNG-HUNG SU; Yang H.-C.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.

Showing items 811-835 of 1268  (51 Page(s) Totally)
<< < 28 29 30 31 32 33 34 35 36 37 > >>
View [10|25|50] records per page